Superior temporal gyrus and the course of early schizophrenia: Progressive, static, or reversible?

Journal of Psychiatric Research

Volumn 32, Issue 3-4, 1998, Pages 161-167

  Keshavan, Matcheri S ^a   Haas, Gretchen L ^a   Kahn, Charles E ^a   Aguilar, Eduardo ^a   Dick, Elizabeth L ^a   Schooler, Nina R ^a   Sweeney, John A ^a   Pettegrew, Jay W ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; MALE; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHIZOPHRENIA; TEMPORAL CORTEX;

ADULT; AGE FACTORS; DISEASE PROGRESSION; DOPAMINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; SCHIZOPHRENIA; TEMPORAL LOBE;

EID: 0032073135     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(97)00038-1     Document Type: Article

References (49)

1. American Psychiatric Association (1987). Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Press.
2. Annett, M., & Manning, M. (1990). Arithmetic and laterality. Neuropsychologia, 28, 61-69.
3. Barta, P. E., Pearlson, G. D., Powers, R. E., Richards, S. S., & Tune, L. E. (1990). Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. American Journal of Psychiatry, 147, 1457-1462.
4. Beiser, M., Erickson, D., Fleming, J. A., & Iacono, W. G. (1993). Establishing the onset of psychotic illness. American Journal of Psychiatry, 150, 1349-1354.
5. Bilder, R. M., Lipschutz-Broch, L., Reiter, G., Geisler, S. H., Mayerhoff, D. I., & Lieberman, J. A. (1992). Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophrenia Bulletin, 18, 437-448.
6. Bogerts, B., Ashtari, M., Degreef, G., Alvir, J. M., Bilder, R. M., & Lieberman, J. A. (1990). Reduced temporal limbic structure volume on magnetic resonance images in first-episode schizophrenia. Psychiatry Research, 35, 1-13.
7. Bogerts, B., Lieberman, J. A., Ashtari, M., Bilder, R., Degreef, G., Lerner, G., Johns, C., & Masiar, S. (1993). Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biological Psychiatry, 33, 236-246.
8. Chakos, M. H., Lieberman, J. A., Bilder, R. M., Lerner, G., Bogerts, B., Wu, H., Kinon, B., & Ashtari, M. (1994). Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. American Journal of Psychiatry, 151, 1430-1436.
9. DeLisi, L. E., Hoff, A. L., Schwartz, J. E., Shields, G. W., Halthore, S. N., Gupta, S. M., Henn, F. A., & Anand, A. K. (1991). Brain morphology in first-episode schizophrenic-like psychotic patients: A quantitative magnetic resonance imaging study. Biological Psychiatry, 29, 159-175.
10. DeLisi, L. E., Tew, W., Xie, S., Hoff, A. L., Sakuma, M., Kushner, M., Lee, G., Shedlack, K., Smith, A. M., & Grimson, R. (1995). A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biological Psychiatry, 38, 349-360.
11. Haas, G. L., Keshavan, M. S., & Sweeney, J. A. (1994). Delay to first medication in schizophrenia: evidence for a possible negative impact of exposure to psychosis. American College of Neuropharmacology, Annual Meeting, 33, 171.
12. Haas, G. L., Sweeney, J. A., Hien, D. A., Goldman, D. & Deck, M. (1991). Gender differences in schizophrenia. Presented at The Third International Congress on Schizophrenia Research, Tucson, AZ, April 21-25, 1991 (abstract). Schizophrenia Research, May/June; 4, 277.
13. Haas, G. L., Sweeney, J. A., Keshavan, M. S., & Schooler, N. R. (1997). Rapid and gradual reconstitutive processes in schizophrenia (abstract). Schizophrenia Research, 24, 106.
14. Hoff, A. L., Wieneke, M., Horon, R., Sakuma, M., Nordahl, T., & DeLisi, L. E. (1997). Longitudinal neuropsychological findings from Stony Brook first episode study (abstract). Schizophrenia Research, 24, 108.
15. Hollingshead, A. B. (1975). Four factor index of social class. New Haven, CT: Yale University Press.
16. Jaskiw, G. E., Juliano, D. M., Goldberg, T. E., Hertzman, M., Urow-Hamell, E., Weinberger, D. R. (1994). Cerebral ventricular enlargement in schizophreniform disorder does not progress. A seven year follow-up study. Schizophrenia Research, 14, 23-28.
17. Keshavan, M. S., Bagwell, W. W., Haas, G. L., Sweeney, J. A., Schooler, N. R., & Pettegrew, J. A. (1994). Changes in caudate volume with neuroleptic treatment. The Lancet, 344, 1434.
18. Keshavan, M. S., Beckwith, C., Bagwell, W., Pettegrew, J. W., & Krishnan, K. R. (1994). An objective method for edge detection in MRI morphometry. European Psychiatry, 9, 205-207.
19. Keshavan, M. S., & Schooler, N. R. (1992). First-episode studies in schizophrenia: criteria and characterization. Schizophrenia Bulletin, 18, 491.
20. Knoll, J. L., Garver, D. L., Ramberg, J. E., Kingsburg, S. J., Croissant, D. & McDermott, B. (in press). Heterogeneity of the psychoses: Is there a neurodegenerative psychosis? Schizophrenia Bulletin.
21. Lammers, C. H., Garcia-Borreguero, D., Schmider, J., Gotthardt, U., Dettling, M., Holsboer, F., & Heuser, I. J. (1995). Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal contros: II. Biological Psychiatry, 38, 803-807.
22. Langendorf, F. G., Anderson, D. C., Tupper, D. E., Rottenberg, D. A., & Weisman, I. D. (1996). Brain atrophy and chronic cocaine abuse: background and work in progress. NIDA Research Monograph, 163, 27-42.
23. Lieberman, J. A., Bogerts, B., Degreef, G., Ashtari, M., & Alvir, J. (1992). Qualitative assessment of brain morphology in acute and chronic schizophrenia. American Journal of Psychiatry, 149, 784-794.
24. Lim, K. O., Harris, D., Beal, M., Hoff, A. L., Minn, K., Csernansky, J. G., Faustman, W. O., Marsh, L., Sullivan, E. V., & Pfefferbaum, A. (1996). Gray matter deficits in young onset schizophrenia are independent of age of onset. Biological Psychiatry, 40, 4-13.
25. Marsh, L., Suddath, R. L., Higgins, N., Weinberger, D. R. (1994). Medial temporal lobe structures in schizophrenia: relationship of size to duration of illness. Schizophrenia Research, 11, 225-238.
26. McCarley, R. W., Shenton, M. E., O'Donnell, B. F., Fauz, S. F., Kikinis, R., Nestor, P. G., & Jolesz, F. A. (1993). Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia. Archives of General Psychiatry, 50, 190-197.
27. McEwen, B. S. (1997). Possible mechanisms for atrophy of the human hippocampus. Molecular Psychiatry, 2, 255-262.
28. McGlashan, T. H., Johannessen, J. O. (1996). Early detection and intervention with schizophrenia: rationale. Schizophrenia Bulletin, 22, 201-217.
29. Meshul, C. K., Buckman, J. F., Allen, C., Riggan, J. P., & Feller, D. J. (1996). Activation of corticostriatal pathway leads to similar morphological changes observed following haloperidol treatment. Synapse, 22, 350-361.
30. Mukherjee, S., & Mahadik, S. P. (1994). A new paradigm for schizophrenia? (review). Schizophrenia Bulletin, 13, 191-194.
31. Nestor, P. G., Shenton, M. E., McCarley, R. W., Haimson, J., Smith, R. S., O'Donnell, B. F., Kimble, M. O., Kikinis, R., & Jolesz, F. A. (1993). Neuropsychological correlations of MRI temporal lobe abnormalities in schizophrenia. American Journal of Psychiatry, 150, 1849-1855.
32. Nopoulos, P., Flashman, L., Flaum, M., Arndt, S., & Andreasen, N. (1994). Stability of cognitive functioning early in the course of schizophrenia. Schizophrenia Research, 14, 29-37.
33. O'Brien, J. T. (1997). The 'glucocorticoid cascade' hypothesis in man. Prolonged stress may cause permanent brain damage. The British Journal of Psychiatry, 170, 199-201.
34. O'Donnell, B. F., Shenton, M. E., McCarley, R. W., Faux, S. F., Smith, R. S., Salisbury, D. F., Nestor, P. G., Pollak, S. D., Kikinis, R., & Jolesz, F. A. (1993). The auditory N2 component in schizophrenia: relationship to MRI temporal lobe gray matter and to other ERP abnormalities. Biological Psychiatry, 34, 26-40.
35. Overall, J. E., & Gorham, D. R. (1962). The brief psychiatric rating scale. Psychological Reports, 10, 779-812.
36. Rasband, W. (1993). NIH Image Manual. Bethesda, MD: National Institutes of Health.
37. Rosenberg, D., Keshavan, M.S., Bagwell, W., Seymour, A., O'Hearn, K., Dick, E. & Birmaher, B. (1997). Caudate nucleus and putamen abnormalities in pediatric OCD. Archives of General Psychiatry.
38. Ross, C. A., & Pearlson, G. D. (1996). Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach. Trends in Neurosciences, 19, 171-176.
39. Selemon, L. D., Lidow, M. S., Goldman-Rakic, P. S. (1997). Chronic neuroleptic drug treatment induces mild gliosis in the prefrontal cortex of rhesus monkeys (abstract). Schizophrenia Research, 24, 266-267.
40. Shenton, M. E., Kikinis, R., Jolesz, F. A., Pollak, S. D., M, L., Wible, C. G., Hokama, H., Martin, J., Metcalf, D., Coleman, M., & McCarley, R. W. (1992). Abnormalities of the left temporal lobe and thought disorder in schizophrenia: a quantitative magnetic resonance imaging study. New England Journal of Medicine, 327, 604-612.
41. Simantov, R., Blinder, E., Ratovitski, T., Tauber, M., Gabbay, M., & Porat, S. (1996). Dopamine-induced apoptosis in human neuronal cells: inhibition by nucleic acides antisense to the dopamine transporter. Neuroscience, 74, 39-50.
42. Spitzer, R. L., Williams, J. B. W., Gibbon, M. & First, M. (1990). Structured Clinical Interview for DSM-III-R, Patient Edition. Washington, DC: American Psychiatric Press.
43. Suddath, R. L., Christison, G. W., Torrey, E. F., Casanova, M. F., Weinberger, D. R. (1990). Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. New England Journal of Medicine, 322, 789-794.
44. Sweeney, J. A., Haas, G. L., & Li, S. (1992). Neuropsychological and eye movement abnormalities in first-episode and chronic schizophrenia. Schizophrenia Bulletin, 18, 282-293.
45. Szymanski, S. R., Cannon, T. D., Gallacher, F., Erwin, R. J., & Gur, R. E. (1996). Course of treatment response in first-episode and chronic schizophrenia. American Journal of Psychiatry, 153, 519-525.
46. Szymanski, S. R., Cannon, T. D., Gallacher, F., Erwin, R. J., & Gur, R. E. (1996). Course of treatment response in first-episode and chronic schizophrenia. American Journal of Psychiatry, 153, 519-525.
47. Weinberger, D. R. (1995). From neuropathology to neurodevelopment. Lancet, 346, 552-557.
48. Wik, G. (1995). Effects of neuroleptic treatment on cortisol and 3-methoxy-4-hydroxyphenylethyl glycol levels in blood. Journal of Endocrinology, 144, 425-429.
49. Wyatt, R. J. (1991). Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin, 17, 325-351.